Vaccination strategy | £, versus halted vac. (3.5%) | £, versus girls’ vac. (3.5%) | £, versus halted vac. (1.5%) | £, versus girls’ vac. (1.5%) |
---|---|---|---|---|
Girls, bivalent | 55.80 (55.04 – 56.57) | - | 687.47 (675.62 – 699.20) | - |
Girls, quadrivalent | 99.64 (98.90 – 100.37) | - | 752.46 (740.51 – 764.72) | - |
Girls, nonavalent | 108.05 (107.36 – 108.75) | - | 811.44 (801.18 – 821.68) | - |
Girls & boys, bivalent | 25.08 (24.64 – 25.52) | -5.67 (-6.42 – -4.93) | 361.99 (356.09 – 367.85) | 36.46 (26.82 – 45.98) |
Girls & boys, quadrivalent | 48.38 (47.95 – 48.80) | -2.92 (-3.64 – -2.18) | 398.68 (392.65 – 404.84) | 44.70 (35.42 – 53.81) |
Girls & boys, nonavalent | 52.77 (52.42 – 53.10) | -2.56 (-3.13 – -1.99) | 429.26 (422.98 – 435.44) | 46.88 (37.63 – 56.46) |